Eribulin Impurities and its Related Products
Displaying
14 results of
Eribulin Impurities
Eribulin is an anti-cancer drug used to treat breast cancer and liposarcoma. Eribulin Impurities are the unwanted substances that may be present in the drug during its manufacturing process. These impurities can affect the purity, quality and safety of the drug, and can also impact the effectiveness of the treatment. Therefore, it is important to identify and control these impurities to ensure that the drug is safe and effective for use in patients.